ReproCell Surges 472 Percent Above IPO Price on First Day

ReproCell Inc., a stem-cell medical research company, closed its trading debut today more than five times higher than its initial public offering price, the biggest jump for an IPO over $10 million in Japan since 1999.

http://washpost.bloomberg.com/Story?docId=1376-MP2THP6JTSEQ01-2RSA136ONA23NEJ9D5JVG3VJAN